Sorafenib induces autophagy in human myeloid dendritic cells and prolongs survival of skin allografts

Transplantation

Volumn 95, Issue 6, 2013, Pages 791-800

  Lin, Jiunn Chang ^a,b,c   Huang, Wei Pang ^d   Liu, Chien Liang ^b,c   Lee, Jie Jen ^b,e   Liu, Tsang Pai ^b,c   Ko, Wen Chin ^b   Huang, Yu Chuen ^f   Hsu, Ming Ling ^b   Wu, Chih Hsiung ^a,g   Chen, Yu Jen ^b,e,g,h  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c Nursing   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^h CHINESE CULTURE UNIVERSITY   (Taiwan)

Author keywords

Allograft tolerance; Autophagy; Dendritic cell; mTOR; Sorafenib

Indexed keywords

7 AMINODACTINOMYCIN; CARRIER PROTEIN; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; LIGHT CHAIN 3; LIGHT CHAIN 3 B I; LIGHT CHAIN 3 B II; MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE ANTIGEN; S6 KINASE; SORAFENIB; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 7-AMINOACTINOMYCIN D; ANTIGEN; CARBANILAMIDE DERIVATIVE; DACTINOMYCIN; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; NICOTINAMIDE; PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL DIFFERENTIATION; CELL MATURATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MALE; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKIN ALLOGRAFT; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ALLOTRANSPLANTATION; ANIMAL; BONE MARROW CELL; CELL SURVIVAL; DENDRITIC CELL; FLUORESCENCE MICROSCOPY; METABOLISM; METHODOLOGY; SKIN TRANSPLANTATION;

ANIMALS; ANTIGENS; AUTOPHAGY; CELL SURVIVAL; DACTINOMYCIN; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICE; MICROSCOPY, FLUORESCENCE; MYELOID CELLS; NIACINAMIDE; PHENYLUREA COMPOUNDS; PROTEIN KINASE INHIBITORS; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

MLCS; MLOWN;

EID: 84877604813     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31827fac48     Document Type: Article

References (43)

1. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006; 311: 17.
2. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767.
3. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7: 610.
4. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685.
5. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002; 23: 445.
6. + T cells. J Immunol 2005; 174: 7433.
7. Rastellini C, Lu L, Ricordi C, et al. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60: 1366.
8. Lutz MB, Kukutsch NA, Menges M, et al. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur J Immunol 2000; 30: 1048.
9. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659.
10. Mizushima N, Ohsumi Y, Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct Funct 2002; 27: 421.
11. Orvedahl A, MacPherson S, Sumpter R Jr, et al. Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe 2010; 7: 115.
12. Gutierrez MG, Master SS, Singh SB, et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004; 119: 753.
13. Andrade RM, Wessendarp M, Gubbels MJ, et al. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. J Clin Invest 2006: 116: 2366.
14. Prentice E, Jerome WG, Yoshimori T, et al. Coronavirus replication complex formation utilizes components of cellular autophagy. J Biol Chem 2004; 279: 10136.
15. Wilhelm SM, Carter C, Tang L, et al. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res 2004; 64: 7099.
16. Brugarolas J. Renal-cell carcinomaVmolecular pathways and therapies. N Engl J Med 2007; 356: 185.
17. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepa-tocellular carcinoma. N Engl J Med 2008; 359: 378.
18. Gabrilovich D, Ishida T, Oyama T, et al. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 1998; 92: 4150.
19. Mimura K, Kono K, Takahashi A, et al. Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2. Cancer Immunol Immunother 2007; 56: 761.
20. + dendritic cells in vivo. J Exp Med 2003; 198: 305.
21. Kingston D, Schmid MA, Onai N, et al. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 2009; 114: 835.
22. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J Exp Med 1995; 182: 1111.
23. Krishnamoorthy N, Oriss TB, Paglia M, et al. Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat Med 2008; 14: 565.
24. Hipp MM, Hilf N, Walter S, et al. Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses. Blood 2008; 111: 5610.
25. Abe M, Metes D, Thomson AW. Dendritic cells and regulation of alloimmune responses: relevance to outcome and therapy of organ transplantation. Expert Rev Clin Immunol 2005; 1: 419.
26. Barratt-Boyes SM, Thomson AW. Dendritic cells: tools and targets for transplant tolerance. Am J Transplant 2005: 5: 2807.
27. Thomson AW, Turnquist HR, Zahorchak AF, et al. Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance. Transplantation 2009; 87: S86.
28. Bellodi C, Lidonnici MR, Hamilton A, et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest 2009; 119: 1109.
29. Dorfel D, Appel S, Grunebach F, et al. Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA. Blood 2005; 105: 3199.
30. Schmid D, Pypaert M, Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007; 26: 79.
31. Lee HK, Lund JM, Ramanathan B, et al. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007; 315: 1398.
32. Jagannath C, Lindsey DR, Dhandayuthapani S, et al. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 2009; 15: 267.
33. Reichardt W, Durr C, von Elverfeldt D, et al. Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation. J Immunol 2008; 181: 4770.
34. Fischer R, Turnquist HR, Taner T, et al. Use of rapamycin in the induction of tolerogenic dendritic cells. Handb Exp Pharmacol 2009; 188: 215.
35. Taner T, Hackstein H, Wang Z, et al. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce Ag-specific T cell regulation and prolong graft survival. Am J Transplant 2005; 5: 228.
36. + T regulatory cells and promote organ transplant tolerance. J Immunol 2007; 178: 7018.
37. Gedaly R, Angulo P, Hundley J, et al. PI-103 and sorafenib inhibit he-patocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways. Anticancer Res 2010; 30: 4951.
38. Reding R, Gras J, Truong DQ, et al. The immunological monitoring of alloreactive responses in liver transplant recipients: a review. Liver Transpl 2006; 12: 373.
39. Park SJ, Nakagawa T, Kitamura H, et al. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 2004; 173: 3844.
40. Davidson C, Verma ND, Robinson CM, et al. IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation. Transpl Immunol 2007; 17: 178.
41. Lee JJ, Liao HF, Yang YC, et al. Platonin modulates differentiation and maturation of human monocyte-derived dendritic cells. Int Immu-nopharmacol 2006; 6: 287.
42. Chen YJ, Huang WP, Yang YC, et al. Platonin induces autophagy-associated cell death in human leukemia cells. Autophagy 2009; 5: 173.
43. Tomita Y, Mayumi H, Eto M, et al. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance? J Immunol 1990; 144: 463.